Nine Masts Capital’s Lunai Bioworks LNAI Stock Holding History

Nine Masts Capital’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,803	Closed	-$41.7K	–	275
2026 Q1	$41.7K	Buy	12,803 +9,775	+323%	+$48.5K	0.01%	170
2025 Q4	$21.4K	Buy	+3,028	New	+$27K	﹤0.01%	104

Other funds holding LNAI

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Nine Masts Capital's LNAI Position: Q2 2026 in Review

Nine Masts Capital sold out of Lunai Bioworks (LNAI) in Q2 2026, closing a stake of 12,803 shares — an estimated $41.7K sold.

Nine Masts Capital first reported a position in LNAI in Q4 2025 and held it in 2 quarters. The position peaked at $41.7K in Q1 2026. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

Nine Masts Capital reported no remaining Lunai Bioworks position as of Q2 2026 after selling out during the quarter.
Nine Masts Capital sold 12,803 Lunai Bioworks shares in Q2 2026, an estimated $41.7K.
Nine Masts Capital first reported a position in Lunai Bioworks in Q4 2025 and held it in 2 quarters.
Nine Masts Capital's Lunai Bioworks position peaked at $41.7K in Q1 2026.
15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.